Author:
Zhang Yuan,Wang Cheng-wei,Wang Zhi-gang,Ma Dao-xin,Pan Shun,Zhu Shu-gan,Li Feng,Wang Bo
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Neurology (clinical),Neurology,Oncology
Reference32 articles.
1. Hau P, Fabel K, Baumqart U et al (2004) Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade glioma. Cancer 100:1199–1207
2. Comerford KM, Wallace TJ, Karhausen J et al (2002) Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res 62:3387–3394
3. Montaudon D, Benchekroun MN, Londos-Gagliardi et al (1990) Chromosomal modification of a rat glioblastoma cell line during the acquisition and reversal of doxorubicin resistance. Anticancer Res 10:1667–1676
4. Ogretmen B, Ahmad R (1999) Negative regulation of MDR1 promoter activity in MCF-7, but not in multidrug resistant MCF-7/Adr, cells by cross-coupled NF-II B/p65 and c-Fos. Transcription factors and their interaction with the CAAT region. Biochemistry 38:2189–2199
5. Kartner N, Evernden-Porelle D, Bradley G et al (1985) Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies. Nature 316:820–823
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献